Mobilization of hematopoietic stem cells for use in autologous transplantation

Clinical Journal of Oncology Nursing

Volumn 14, Issue 2, 2010, Pages 212-222

  Devine, Hollie ^a   Kathryn Tierney, D ^b   Schmit Pokorny, Kim ^c   McDermott, Kathleen ^d  

^a OHIO STATE UNIVERSITY   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APHERESIS; AUTOTRANSPLANTATION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; METHODOLOGY; REVIEW; STEM CELL MOBILIZATION;

BLOOD COMPONENT REMOVAL; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; TRANSPLANTATION, AUTOLOGOUS;

EID: 77955285513     PISSN: 10921095     EISSN: 1538067X     Source Type: Journal    
DOI: 10.1188/10.CJON.212-222     Document Type: Review

References (65)

1. Alegre, A., Tomas, J.F., Martinez-Chamorro, C., Gil-Fernandez, J.J., Fernandez-Villalta, M.J., Arranz, R., Fernandez-Ranada, J.M. (1997). Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: High-dose cyclophosphamide plus GM-CSF vs G-CSF alone. Bone Marrow Transplantation, 20, 211-217. doi: 10.1038/sj.bmt.1700867
2. Amgen Inc. (2007). Filgrastim [Package insert]. Thousand Oaks, CA: Author.
3. Anderson, W. (1999). Integrated medical sciences: Immunology. Madison, WI: Fence Creek.
4. Becker, P.S., Wagle, M., Matous, S., Swanson, R.S., Pihan, G., Lowry, P.A., Heard, S.O. (1997). Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): Occurrence in an allogeneic donor of peripheral blood stem cells. Biology of Blood and Marrow Transplantation, 3, 45-49.
5. Bensinger, W., Appelbaum, F., Rowley, S., Storb, R., Sanders, J., Lilleby, K., Weaver, C. (1995). Factors that influence collection and engraftment of autologous peripheral-blood stem cells. Journal of Clinical Oncology, 13, 2547-2555.
6. Bensinger, W., DiPersio, J.F., & McCarty, J.M. (2009). Improving stem cell mobilization strategies: Future directions. Bone Marrow Transplantation, 43, 181-195. doi: 10.1038/bmt.2008.410
7. Bishop, M.R., Anderson, J.R., Jackson, J.D., Bierman, P.J., Reed, E.C., Vose, J.M., Kessinger, A. (1994). High-dose therapy and peripheral blood progenitor cell transplantation: Effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft. Blood, 83, 610-616.
8. Bishop, M.R., Jackson, J.D., O'Kane-Murphy, B., Schmit-Pokorny, K., Vose, J.M., Bierman, P.J., Kessinger, A. (1996). Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cells. Journal of Clinical Oncology, 14, 2521-2526.
9. Broxmeyer, H.E., & Kim, C.H. (1999). Regulation of hematopoiesis in a sea of chemokine family members with a plethora of redundant activities. Experimental Hematology, 27, 1113-1123. doi: 10.1016/S0301-472X(99)00045-4
10. Broxmeyer, H.E., Orschell, C.M., Clapp, D.W., Hangoc, G., Cooper, S., Plett, P.A., Srour, E.F. (2005). Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. Journal of Experimental Medicine, 201, 1307-1318. doi: 10.1084/jem.20041385
11. Burger, J.A., & Peled, A. (2009). CXCR4 antagonists: Targeting the microenvironment in leukemia and other cancers. Leukemia, 23, 43-52. doi: 10.1038/leu.2008.299
12. Calandra, G., McCarty, J., McGuirk, J., Tricot, G., Crocker, S.A., Badel, K., Bridger, G. (2008). AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: Compassionate use data. Bone Marrow Transplantation, 41, 331-338. doi: 10.1038/sj.bmt.1705908
13. Cannon, J.G. (2000). Inflammatory cytokines in nonpathological states. News in Physiological Sciences, 15, 298-303.
14. Dazzi, C., Cariello, A., Rosti, G., Argnani, M., Sebastiani, L., Ferrari, E., Marangolo, M. (2000). Is there any difference in PBPC mobilization between cyclophosphamide plus G-CSF and G-CSF alone in patients with non-Hodgkin's lymphoma? Leukemia and Lymphoma, 39, 301-310.
15. Desikan, K.R., Barlogie, B., Jagannath, S., Vesole, D.H., Siegel, D., Fassas, A., Tricot, G. (1998). Comparable engraftment kinetics following peripheral-blood stem-cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma. Journal of Clinical Oncology, 16, 1547-1553.
16. Devine, S.M., Flomenberg, N., Vesole, D.H., Liesveld, J., Weisdorf, D., Badel, K., DiPersio, J.F. (2004). Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma. Journal of Clinical Oncology, 22, 1095-1102. doi: 10.1200/JCO.2004.07.131
17. DiPersio J.F., Micallef, I.N., Stiff, P.J., Bolwell, B.J., Maziarz, R.T., Jacobsen, E., 3101 Investigators. (2009). Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma. Journal of Clinical Oncology, 27, 4767-4773.
18. DiPersio, J.F., Stadmauer, E.A., Nademanee, A., Micallef, I.N., Stiff, P.J., Kaufman, J.L., 3102 Investigators. (2009). Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma. Blood, 113, 5720-5726.
19. Flomenberg, N., Devine, S.M., Dipersio, J.F., Liesveld, J.L., McCarty, J.M., Rowley, S.D., Calandra, G. (2005). The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. Blood, 106, 1867-1874. doi: 10.1182/blood-2005-02-0468
20. Gazitt, Y. (2002). Comparison between granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the mobilization of peripheral blood stem cells. Current Opinion in Hematology, 9, 190-198. doi: 10.1097/00062752-200205000-00003
21. Genzyme Corporation. (2008). Plerixifor [Package insert]. Cambridge, MA: Author.
22. Glaspy, J.A., Shpall, E.J., LeMaistre, C.F., Briddell, R.A., Menchaca, D.M., Turner, S.A., McNiece, I.K. (1997). Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients. Blood, 90, 2939-2951.
23. Goterris, R., Hernandez-Boluda, J.C., Teruel, A., Gomez, C., Lis, M.J., Terol, M.J., Arbona, C. (2005). Impact of different strategies of second-line stem cell harvest on the outcome of autologous transplantation in poor peripheral blood stem cell mobilizers. Bone Marrow Transplantation, 36, 847-853. doi: 10.1038/sj.bmt.1705147
24. Haas, R., Mohle, R., Fruhauf, S., Goldschmidt, H., Witt, B., Flentje, M., Hunstein, W. (1994). Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood, 83, 3787-3794.
25. Hendrix, C.W., Collier, A.C., Lederman, M.M., Schols, D., Pollard, R.B., Brown, S., AMD3100 HIV Study Group. (2004). Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes, 37, 1253-1262. doi: 10.1097/01.qai.0000137371.80695.ef
26. Hooper, P.J., & Santos, E.J. (1993). Peripheral blood stem cell transplantation. Oncology Nursing Forum, 20, 1215-1221.
27. Hynes, R.O. (2002). Integrins: Bidirectional, allosteric signaling machines. Cell, 110, 673-687. doi: 10.1016/S0092-8674(02)00971-6
28. Kessinger, A., & Sharp, J.G. (2003). The whys and hows of hematopoietic progenitor and stem cell mobilization. Bone Marrow Transplantation, 31, 319-329. doi: 10.1038/sj.bmt.1703837
29. Kessinger, A.M., & Sharp, G. (1996). Mobilization of hematopoietic progenitor cells with epoetin alfa. Seminars in Hematology, 33(1, Suppl. 1), 10-15.
30. Koc, O.N., Gerson, S.L., Cooper, B.W., Laughlin, M., Meyerson, H., Kutteh, L., Lazarus, H.M. (2000). Randomized cross-over trial of progenitor-cell mobilization: High-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF. Journal of Clinical Oncology, 18, 1824-1830.
31. Laing, K.J., & Secombes, C.J. (2004). Chemokines. Developmental and Comparative Immunology, 28, 443-460. doi: 10.1016/j.dci.2003.09.006
32. Lapidot, T., & Petit, I. (2002). Current understanding of stem cell mobilization: The roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Experimental Hematology, 30, 973-981. doi: 10.1016/S0301-472X(02)00883-4
33. Lataillade, J.J., Domenech, J., & Le Bousse-Kerdiles, M.C. (2004). Stromal cell-derived factor-1 (SDF-1)\CXCR4 couple plays multiple roles on haematopoietic progenitors at the border between the old cytokine and new chemokine worlds: Survival, cell cycling and trafficking. European Cytokine Network, 15, 177-188.
34. Liles, W.C., Broxmeyer, H.E., Rodger, E., Wood, B., Hubel, K., Cooper, S., Dale, D.C. (2003). Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood, 102, 2728-2730. doi: 10.1182/blood-2003-02-0663
35. Mamula, M. (1999). Cells of the reticuloendothelial system. In M. Mamula (Ed.), Quick look immunology (pp. 4-5). Madison, WI: Fence Creek.
36. Manz, M., Akashi, K., & Weissman, I. (2004). Biology of hematopoietic stem and progenitor cells. In F.R. Applebaum, S.J. Forman, R.S. Negrin, & K.G. Blume (Eds.), Thomas' hematopoietic cell transplantation (3rd ed., pp. 69-95). Malden, MA: Blackwell.
37. McAdams, F. (2004). Transplant course. In S. Ezzone (Ed.), Hematopoietic stem cell transplantation: A manual for nursing practice (pp. 43-59). Pittsburgh, PA: Oncology Nursing Society.
38. McGrath, K.E., Koniski, A.D., Maltby, K.M., McGann, J.K., & Palis, J. (1999). Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4. Developmental Biology, 213, 442-456. doi: 10.1006/dbio.1999.9405
39. Moog, R. (2001). Adverse events in peripheral progenitor cell collection: A 7-year experience. Journal of Hematotherapy and Stem Cell Research, 10, 675-680. doi: 10.1089/152581601753193896
40. Nademanee, A., Sniecinski, I., Schmidt, G.M., Dagis, A.C., O'Donnell, M.R., Snyder, D.S., Molina, A. (1994). High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells. Journal of Clinical Oncology, 12, 2176-2186.
41. Narayanasami, U., Kanteti, R., Morelli, J., Klekar, A., Al-Olama, A., Keating, C., Schenkein, D.P. (2001). Randomized trial offilgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation. Blood, 98, 2059-2064. doi: 10.1182/blood.V98.7.2059
42. Ng-Cashin, J.S. (2004). Mobilization of autologous peripheral blood hematopoietic cells for support of high-dose cancer therapy. In F.R. Applebaum, S.J. Forman, R.S. Negrin, & K.G. Blume (Eds.), Thomas' hematopoietic cell transplantation (3rd ed., pp. 576-587). Malden, MA: Blackwell.
43. Pavone, V., Gaudio, F., Guarini, A., Perrone, T., Zonno, A., Curci, P., & Liso, V. (2002). Mobilization of peripheral blood stem cells with high-dose cyclophosphamide or the DHAP regimen plus G-CSF in non-Hodgkin's lymphoma. Bone Marrow Transplantation, 29, 285-290. doi: 10.1038/sj.bmt.1703364
44. Pusic, I., Jiang, S.Y., Landua, S., Uy, G.L., Rettig, M.P., Cashen, A.F., DiPersio, J.F. (2008). Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation. Biology of Blood and Marrow Transplantation, 14, 1045-1056. doi: 10.1016/j.bbmt.2008.07.004
45. Reed, E.F. (1992). Nursing for patients receiving high-dose chemotherapy with hematopoietic rescue. In K.H. Armitage (Ed.), High-dose cancer therapy: Pharmacology, hematopoietins, stem cells (pp. 405-418). Baltimore, MD: Williams and Wilkins.
46. Richman, C.M., Weiner, R.S., & Yankee, R.A. (1976). Increase in circulating stem cells following chemotherapy in man. Blood, 47, 1031-1039.
47. Rowley, S. (2000). Practical aspects of stem cell collection. In R. Hoffman, E. Benz, B. Furie, H. Cohen, L. Silberstein, & P. McGlave (Eds.), Hematology basic principles and practice (3rd ed., pp. 1647-1650). New York, NY: Churchill Livingstone.
48. Rowley, S.D. (2004). Cryopreservation of hematopoietic cells. In F.R. Applebaum, S.J. Forman, R.S. Negrin, & K.G. Blume (Eds.), Thomas' hematopoietic cell transplantation (3rd ed., pp. 599-612). Malden, MA: Blackwell.
49. Schiller, G., Vescio, R., Freytes, C., Spitzer, G., Sahebi, F., Lee, M., Hong, C.H. (1995). Transplantation of CD34+ peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood, 86, 390-397.
50. Schmit-Pokorny, K. (2004). Stem cell collection. In S. Ezzone (Ed.), Hematopoietic stem cell transplantation: A manual for nursing practice (pp. 23-42). Pittsburgh, PA: Oncology Nursing Society.
51. Schmitz, N., Linch, D.C., Dreger, P., Goldstone, A.H., Boogaerts, M.A., Ferrant, A., Barge, A. (1996). Randomised trial of filgrastimmobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet, 347, 353-357. doi: 10.1016/S0140-6736(96)90536-X
52. Scholossman, S., Boumsell, L., Kishimoto, T., Knapp, W., Mason, D., & McMichael, A. (1997). CD antigens 1996: Updated nomenclature for clusters of differentiation on human cells. IUIS/WHO Subcommittee on CD Nomenclature Bull World Health Organization.
53. Smith, T.J., Hillner, B.E., Schmitz, N., Linch, D.C., Dreger, P., Goldstone, A.H., Erder, M.H. (1997). Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma. Journal of Clinical Oncology, 15, 5-10.
54. Socinski, M.A., Cannistra, S.A., Elias, A., Antman, K.H., Schnipper, L., & Griffin, J.D. (1988). Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet, 1, 1194-1198. doi: 10.1016/S0140-6736(88)92012-0
55. Staber, P.B., Holub, R., Linkesch, W., Schmidt, H., & Neumeister, P. (2005). Fixed-dose single administration of pegfilgrastim vs daily filgrastim in patients with haematological malignancies undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation, 35, 889-893. doi: 10.1038/sj.bmt.1704927
56. Stem Cell Information. (2006). Scientific literature. Retrieved from http://stemcells.nih.gov/research/scilit/defaultpage
57. Stiff, P.J. (1999). Management strategies for the hard-to-mobilize patient. Bone Marrow Transplantation, 23(Suppl. 2), S29-S33. doi: 10.1038/sj.bmt.1701671
58. Tarella, C., Di Nicola, M., Caracciolo, D., Zallio, F., Cuttica, A., Omede, P., Gianni, A.M. (2002). High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: An indication for patients at risk for low mobilization. Bone Marrow Transplantation, 30, 725-732. doi: 10.1038/sj.bmt.1703729
59. To, L.B., Shepperd, K.M., Haylock, D.N., Dyson, P.G., Charles, P., Thorp, D.L., Sage, R.E. (1990). Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood. Experimental Hematology, 18, 442-447.
60. Vogel, W., Kunert, C., Blumenstengel, K., Fricke, H.J., Kath, R., Sayer, H.G., Hoffken, K. (1998). Correlation between granulocyte/macrophage-colony-forming units and CD34+ cells in apheresis products from patients treated with different chemotherapy regimens and granulocyte-colony-stimulating factor to mobilize peripheral blood progenitor cells. Journal of Cancer Research and Clinical Oncology, 124, 341-345. doi: 10.1007/s004320050180
61. Vose, J., Kessinger, A., Bierman, P., Sharp, G., Garrison, L., & Armitage, J. (1992). The use of rhIL-3 for mobilization of peripheral blood stem cells in previously treated patients with lymphoma. International Journal of Cell Cloning, 10(Suppl. 1), 62-65. doi: 10.1002/stem.5530100722
62. Weaver, C.H., Schulman, K.A., Wilson-Relyea, B., Birch, R., West, W., & Buckner, C.D. (2000). Randomized trial of filgrastim, sargramostim, or sequential sargramostim and filgrastim after myelosuppressive chemotherapy for the harvesting of peripheral-blood stem cells. Journal of Clinical Oncology, 18, 43-53.
63. Zola, H., Swart, B., Boumsell, L., & Mason, D.Y. (2003). Human leucocyte differentiation antigen nomenclature: Update on CD nomenclature. Report of IUIS/WHO Subcommittee. Journal of Immunological Methods, 275, 1-8.
64. Zola, H., Swart, B., Nicholson, I., Aasted, B., Bensussan, A., Boumsell, L., Warren, H. (2005). CD molecules 2005: Human cell differentiation molecules. Blood, 106, 3123-3126.
65. Zola, H., Swart, B., Nicholson, I., & Voss, E. (2007). Leukocyte and stromal cell molecules: The CD markers. Hoboken, NJ: John Wiley and Sons.